<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04546763</url>
  </required_header>
  <id_info>
    <org_study_id>102238</org_study_id>
    <nct_id>NCT04546763</nct_id>
  </id_info>
  <brief_title>Study Watch AF Detection At Home</brief_title>
  <official_title>Study Watch AF Detection At Home</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Verily Life Sciences LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Verily Life Sciences LLC</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-center, prospective, non-randomized study to evaluate the performance of the&#xD;
      study watch PPG algorithm in detecting irregular rhythms suggestive of atrial fibrillation&#xD;
      (AF) in subjects at risk of having an event of AF in the free living (home) environment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 3, 2020</start_date>
  <completion_date type="Actual">May 14, 2021</completion_date>
  <primary_completion_date type="Actual">May 14, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of AF detection - Sensitivity</measure>
    <time_frame>14 days</time_frame>
    <description>Accuracy of AF detection based on sensitivity observed in a 14-day followup period</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Accuracy of AF detection - Specificity</measure>
    <time_frame>14 days</time_frame>
    <description>Accuracy of AF detection based on specificity observed in a 14-day followup period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>A sensitivity analysis estimating the range of sensitivities</measure>
    <time_frame>14 days</time_frame>
    <description>A sensitivity analysis estimating the range of sensitivities when imputing insufficient quality data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>A sensitivity analysis estimating the range of specificities</measure>
    <time_frame>14 days</time_frame>
    <description>A sensitivity analysis estimating the range of specificities when imputing insufficient quality data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimates of sensitivity by protocol-defined subgroups</measure>
    <time_frame>14 days</time_frame>
    <description>Estimates of sensitivity by protocol-defined subgroups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimates of specificity in subgroups</measure>
    <time_frame>14 days</time_frame>
    <description>Estimates of specificity in subgroups defined by: race, age-groups, site, activity levels, and AF-burden</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimates of positive predictive value (PPV) on the AF-burden</measure>
    <time_frame>14 days</time_frame>
    <description>Estimates of PPV based on the AF-burden observed in the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimates of negative predictive value (NPV) on the AF-burden</measure>
    <time_frame>14 days</time_frame>
    <description>Estimates of NPV based on the AF-burden observed in the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimates of PPV on the AF burden to a screening population</measure>
    <time_frame>14 days</time_frame>
    <description>Estimates of PPV based on the AF burden relevant to a screening population</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimates of NPV on the AF burden to a screening population</measure>
    <time_frame>14 days</time_frame>
    <description>Estimates of NPV based on the AF burden relevant to a screening population</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">117</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Paroxysmal Atrial Fibrillation Patients</arm_group_label>
    <description>This will be a single arm study of patients with paroxysmal atrial fibrillation. Subjects will be wearing the Study Watch and Zio XT Patch concurrently for up to 14 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Study Watch</intervention_name>
    <description>The Study Watch is a miniaturized wearable device made with biocompatible contact materials containing various sensors capable of measuring physiological and environmental metrics.</description>
    <arm_group_label>Paroxysmal Atrial Fibrillation Patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Zio XT</intervention_name>
    <description>The Zio XT Patch, the reference device, is a FDA-cleared single-patient use, continuously recording ECG monitor that can be worn up to 14 days.</description>
    <arm_group_label>Paroxysmal Atrial Fibrillation Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        At risk of having an AF event, as determined by having a diagnosis of paroxysmal AF (PAF)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  At least 22 years old&#xD;
&#xD;
          -  Able to read and speak English&#xD;
&#xD;
          -  Able and willing to sign written Informed Consent&#xD;
&#xD;
          -  Interest in participating in the study&#xD;
&#xD;
          -  At risk of having an AF event, as determined by having a diagnosis of paroxysmal AF&#xD;
             (PAF) and meeting one of the following: (a) scheduled or to be scheduled to undergo AF&#xD;
             ablation, (b) with implantable loop recorder (ILR), implantable cardioverter&#xD;
             defibrillator (ICD), permanent pacemaker (PPM), holter monitor, or adhesive monitoring&#xD;
             patch with documented AF burden of ≥25% in the 3 months prior to consent date, (c)&#xD;
             CHA2DS2VASc ≥3, (d) Left atrial diameter ≥4.4 cm&#xD;
&#xD;
          -  Without significant limitation in ability to participate in the study, in the opinion&#xD;
             of the investigator&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Currently in a paced rhythm&#xD;
&#xD;
          -  Currently on class Ic or class III antiarrhythmic medication that has been successful&#xD;
             in eliminating AF (no documented AF of more than 30 seconds since the initiation of&#xD;
             the medication)&#xD;
&#xD;
          -  Had successful AF ablation (no documented AF of more than 30 seconds post procedure)&#xD;
&#xD;
          -  Known severe allergy to nickel or metal jewelry&#xD;
&#xD;
          -  Known allergic reaction to adhesives or hydrogels or with family history of adhesive&#xD;
             skin allergies&#xD;
&#xD;
          -  Are diagnosed with persistent AF&#xD;
&#xD;
          -  Use of implantable neuro-stimulator&#xD;
&#xD;
          -  Open injury or rash where the study device or comparator will be worn&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hamid Ghanbari</last_name>
    <role>Principal Investigator</role>
    <affiliation>Verily Life Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>San Diego Cardiac Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Colorado Heart and Vascular</name>
      <address>
        <city>Lakewood</city>
        <state>Colorado</state>
        <zip>80228</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ascension Providence Hospital</name>
      <address>
        <city>Southfield</city>
        <state>Michigan</state>
        <zip>48075</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UPMC Pinnacle Harrisburg</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <zip>17011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UT Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 4, 2020</study_first_submitted>
  <study_first_submitted_qc>September 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2020</study_first_posted>
  <last_update_submitted>October 5, 2021</last_update_submitted>
  <last_update_submitted_qc>October 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

